Laurence Bessac

2 Patents

• US126066382026

  Dosing Regimens for Use with PCSK9 Inhibitors

  REGENERON PHARAMACEUTICALS, Inc.

  0 cites
• US120831762024

  Human Antibodies to PCSK9 for Use in Methods of Treating Particular Groups of Subjects

  SANOFI BIOTECHNOLOGY

  0 cites